Targeted Strategies for Today's Evolving Markets

MissionIR Blog

OncoSec Medical Inc. (ONCS) Starts Presentation at LD Micro Conference

Posted on December 2, 2014 by MissionIR

OncoSec Medical Inc. is a biopharmaceutical company developing investigational ImmunoPulse intratumoral cancer immunotherapy. The company’s primary technology is designed to enhance the local delivery and uptake of DNA IL-12 and other DNA-based immune-targeting agents. Clinical studies of ImmunoPulse have demonstrated an acceptable safety profile and preliminary evidence of anti-tumor activity in the treatment of various skin cancers.  For more information, visit the company’s Web site at www.oncosec.com.

The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies. For more information on LD Micro, visit www.ldmicro.com
This entry was posted in LD Micro Conference. Bookmark the permalink.

Comments are closed.